Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trialsJ Behr,I Noth, Wijsenbeek,Martin Kolb,Francesco Bonella,L Moros,Daniel Wachtlin,Tamera J. CortePneumologie(2018)引用 21|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要